Search
supplier_code_of_conduct_2020_PL
supplier_code_of_conduct_2020_KO
Supplier Code of Conduct
EHS management approach
Our comprehensive EHS framework describes our EHS management system at a corporate level consisting of four elements. Click here to find out more.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.
BI Code Of Conduct
Purchasing
Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.
Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
Ethics and Compliance
Find out about our ethical and compliance standards here. Access and view our Speak Up Policy, EFPIA disclosure, and Supplier Code of Conduct.
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
More Potential Overview
More Potential works to provide the best conditions for our people, communities and partners along our value chain. Click here to find out more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
History of the logo
The logo used by Boehringer Ingelheim today is a stylised depiction of the central section of the imperial palace of Charlemagne. Learn more here.
History of Cats
Since the beginning of human civilisation, cats have been companions to people. Click here to learn more about the history of cats with humans.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
Professor Gregory Lip introduces the GLORIA™-AF Registry
In this video, Prof. Gregory Lip introduces the GLORIA™-AF Registry Program. Click here to watch the video and to learn more about the program.
Boehringer Ingelheim announces appointment of Vani Manja as India Country MD
Boehringer Ingelheim has announced that Vani Manja is appointed Country Managing Director for India. Read the press release here and find out more.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Type 2 Diabetes and Risk of Viral Infections
In the current COVID-19 climate, it’s important for everyone to stay safe at home, particularly people living with conditions such as type-2 diabetes.
COVID-19 Mexico - The value of teamwork
During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
Donations of Protective Materials to Healthcare Institutions
Boehringer Ingelheim Mexico donated protective materials to governmental health institutions dedicated to the care of patients with COVID-19. Learn more.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium